Lipitor Attorney Reports on Connection Between Lipitor and Type 2 Diabetes
Lipitor Attorney Comments on “Doublespeak” by Pharmaceutical Companies
Doublespeak is a tool sometimes used by marketers and in propaganda to sell an agenda without the public necessarily being aware of it. The primary method of employing doublespeak is to flood the reader with confusing language and conflicting points so that they will become confused or draw incorrect assumptions. This technique is what certain lawsuits directed at Pfizer are claiming for the warnings on Lipitor.
The warning that came with Lipitor used language such as “disaccharide C12H22011” and “Increases in HbA1c and fast acting serum glucose levels have been reported with HMG-CoA reductase inhibitors, including Lipitor”. These are actually warnings that relate directly to blood sugar levels, with disaccharide C12H22011 being just plain old table sugar. Why say it like that though? Why not in a way that the average person can decipher? These are the questions plaintiffs and their attorneys are asking in the lawsuits.
The Multidistrict Litigation (MDL) brought against Pfizer argues the point that a warning isn’t a warning if the average consumer can’t understand what is being communicated. February of 2012 brought a change in the label that acknowledged that taking Lipitor may result in blood sugar levels changing. Prior to that date, the labeling made no mention of the potential link between Lipitor and Type 2 Diabetes even though it had been established in studies.
A Link Between Lipitor and Type 2 Diabetes
Lipitor is a type of drug called a statin. Statins lower cholesterol by reducing the blood levels of “bad cholesterol”, or low-density lipoprotein (LDL) cholesterol. LDL cholesterol is a significant contributor for the development of heart disease. Statins are regularly prescribed to help combat heart disease in patients.
A study as part of the Women’s Health Initiative found statins increased the potential for Type 2 Diabetes in women (Culver AL, Ockene IS, Balasubramanian R, et al. “Statin Use and Risk of Diabetes Mellitus in Postmenopausal Women in the Women’s Health Initiative.” Archives of Internal Medicine, 2012,172(2): pp.144-152.). The Lipitor attorneys and Plaintiffs in the MDL maintain that there still is no clear language in the Lipitor warning that demonstrates this finding with clarity so that users can make an educated decision regarding their health.
Seeking Compensation For Damages
A Lipitor attorney is important in these kinds of MDL pharmaceutical lawsuits to pursue appropriate compensation for injured patients. If you believe that you or a loved one have developed diabetic health problems from taking Lipitor, contact the American Injury Attorney Group today for a free, no obligation consultation. The AIAG can evaluate your claim and connect you with an affiliated, experienced Lipitor attorney. An experienced Lipitor attorney can help you understand your rights when pursuing a claim.
Time is important in these kinds of cases. Have your case evaluated by the American Injury Attorney Group to see if you should consider filing a Lipitor lawsuit.